- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4418 - Non-condensed pyridinesHydrogenated derivatives thereof having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine
Patent holdings for IPC class A61K 31/4418
Total number of patents in this class: 1540
10-year publication summary
|
111
|
119
|
131
|
121
|
134
|
117
|
126
|
108
|
111
|
67
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Akebia Therapeutics, Inc. | 127 |
32 |
| Bristol-myers Squibb Company | 4764 |
26 |
| Hope Medical Enterprises, Inc. | 56 |
24 |
| io Therapeutics, Inc. | 125 |
23 |
| Novartis AG | 10175 |
21 |
| Vertex Pharmaceuticals Incorporated | 1575 |
20 |
| Excalibur Pharmaceuticals, Inc. | 28 |
20 |
| Avalyn Pharma Inc. | 36 |
19 |
| Kyoto University | 2926 |
16 |
| Boehringer Ingelheim International GmbH | 4485 |
15 |
| Takeda Pharmaceutical Company Limited | 2699 |
15 |
| The George Institute for Global Health | 34 |
15 |
| Medisca Pharmaceutique Inc. | 139 |
13 |
| PureTech Lyt-100, Inc. | 28 |
13 |
| Shionogi & Co., Ltd. | 884 |
12 |
| The Regents of the University of California | 20842 |
11 |
| Bayer Pharma AG | 1009 |
11 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3337 |
11 |
| Fulcrum Therapeutics, Inc. | 55 |
11 |
| F. Hoffmann-La Roche AG | 7800 |
10 |
| Other owners | 1202 |